6-KThe Wire
GSK plc files 6-K
Filed Jun 24, 2026 · 9d ago · Accession 0001654954-26-006168
Plain English
GSK plc has commenced a tender offer to acquire all outstanding shares of Nuvalent, Inc. for $124.00 per share in cash. Nuvalent's Board of Directors has recommended that its stockholders accept the offer.
Filing details
- Company
- GSK plc
- Ticker
- GSK
- CIK
- 1131399
- Form type
- 6-K
- Filing date
- Jun 24, 2026
- Report date
- Jun 24, 2026
- Document
- a6263j.htm
- Size
- 60 KB